...
首页> 外文期刊>Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis >High expression of Musashi-2 indicates poor prognosis in adult B-cell acute lymphoblastic leukemia
【24h】

High expression of Musashi-2 indicates poor prognosis in adult B-cell acute lymphoblastic leukemia

机译:Musashi-2的高表达表明成人B细胞急性淋巴细胞白血病的预后不良

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Musashi-2 (MSI2) expression of 116 adult B-cells acute lymphoblastic leukemia (B-ALL) patients was measured by real-time PCR. Kaplan-Meier analysis showed that patients with high MSI2 expression had inferior overall survival (OS) (P=0.004), event free survival (EFS) (P=0.001) and relapse free survival (RFS) (P=0.018) in BCR-ABL-negative B-ALL. Multivariate models revealed that, besides WBC more than 30×109/L and IK6 variant of IKZF1, high MSI2 expression was also an independent prognostic factor for adult BCR-ABL-negative B-ALL. Our data suggest that high MSI2 expression could indicate poor prognosis and facilitate risk and treatment stratification in adult BCR-ABL-negative B-ALL.
机译:通过实时PCR检测116例成人B细胞急性淋巴细胞白血病(B-ALL)患者的Musashi-2(MSI2)表达。 Kaplan-Meier分析显示,MSR2高表达的患者在BCR-B的总生存期(OS)(P = 0.004),无事件生存期(EFS)(P = 0.001)和无复发生存期(RFS)(P = 0.018)。 ABL阴性B-ALL。多变量模型显示,除了WBC超过IKZF1的30×109 / L和IK6变体之外,MSI2高表达也是成人BCR-ABL阴性B-ALL的独立预后因素。我们的数据表明,MSI2高表达可能预示成人BCR-ABL阴性B-ALL的不良预后并促进风险和治疗分层。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号